Risorse esterne
Opinione della community
Prezzo Variazione Volume
0.468 +8.84 €
P/E Obiettivo ad 1anno
0 6 €

Compra - Vendi

Tutte le tue transazioni per questo titolo

Devi effettuare l'accesso


Altri utenti che hanno investito

Transations in last week
Buy: 60
Sell : 20

Radicchi' wolf nicoladizonno papemix Benedetto Amata comante Lorenzo Simone Bonzanini Re di cuori Claudio Ragaglia LucaMazzu91


Andrea Grimaldi 2015-10-31 16:42
message user image
a me sembra non ci siano problemi...
Simone Bonzanini 2015-10-20 20:36
message user image
Perché non si riesce a comprare?


Acura Pharmaceuticals (ACUR) Receiving Somewhat Positive ... - The Ledger Gazette

Acura Pharmaceuticals (NASDAQ ACUR) traded up 0.00000% during trading on Wednesday, hitting $0.44309. The firm's market cap is $9.21 million. The company has a 50 day moving average of $0.45 and a 200 day moving average of $0.51. Acura ... Leggi

Acura Pharmaceuticals (ACUR) Given Daily News Impact Rating of ... - The Ledger Gazette

Shares of Acura Pharmaceuticals (ACUR) traded down 1.071% during mid-day trading on Thursday, reaching $0.462. 4,200 shares of the company's stock were exchanged. The stock's market cap is $9.61 million. The company has a 50 day moving average ... Leggi

Analysts Anticipate Acura Pharmaceuticals, Inc. (ACUR) Will ... - StockNewsTimes

Acura Pharmaceuticals logo Analysts forecast that Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) will report earnings per share (EPS) of ($0.12) for the current quarter, Zacks reports. Zero analysts have issued estimates for Acura Pharmaceuticals' earnings ... Leggi

A New Spark for Egalet Corp (NASDAQ:EGLT) - The Oracle Dispatch

The company has a collaboration and license agreement with Acura Pharmaceuticals, Inc. to commercialize OXAYDO tablets; and Septodont, Inc. to promote SPRIX Nasal Spray. Egalet Corporation was founded in 2010 and is headquartered in Wayne ...altro » Leggi

Acura Pharmaceuticals Raises $4.0 Million in a Private Placement - GlobeNewswire (press release)

PALATINE, Ill., July 24, 2017 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that it has completed a $4.0 million private placement of its equity ...altro » Leggi

Acura Pharmaceuticals Announces Second Quarter 2017 Financial ... - Nasdaq

PALATINE, Ill., Aug. 14, 2017 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial results for the three and six months ended June 30, 2017.altro » Leggi

Acura Pharmaceuticals Seeks To Raise $5 Million In Offering - Seeking Alpha

Acura Pharmaceuticals has filed to raise $5 million in a follow-on stock and warrant offering. The company is commercializing tamper-resistant medication technologies, but appears to be running out of money and time. It is exploring strategic ... Leggi

Comparing United Continental Holdings (UAL) & The Competition - StockNewsTimes

United Continental Holdings (NYSE: UAL) is one of 31 public companies in the “Airlines” industry, but how does it weigh in compared to its rivals? We will compare United Continental Holdings to related businesses based on the strength of its ...altro » Leggi

Apollo Residential Mortgage (AMTG) Receiving Somewhat Positive ... - StockNewsTimes

Apollo Residential Mortgage logo News articles about Apollo Residential Mortgage (NYSE:AMTG) have trended somewhat positive recently, according to Accern. Accern scores the sentiment of press coverage by reviewing more than twenty million news and ...altro » Leggi

Keep an Eye on These 7 Stocks for January 4, 2017 - Benzinga

... to $26.39 in after-hours trading. HCP, Inc. (NYSE: HCP) appointed Tom Herzog as Chief Executive Officer and also named Justin Hutchens as President. HCP shares rose 0.20 percent to close at $29.78 on Tuesday. Acura Pharmaceuticals, Inc. (NASDAQ: ...altro » Leggi